Department of Paediatrics, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Department of Paediatrics, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
J Glob Antimicrob Resist. 2024 Mar;36:473-481. doi: 10.1016/j.jgar.2024.01.011. Epub 2024 Jan 26.
Point prevalence surveys (PPS) provide valuable data on patterns of hospital antimicrobial administration. To identify quality improvement indicators, we evaluated antimicrobial prescribing patterns in children and neonates admitted to three referral centres in Sanandaj, Western Iran, and compared these with Southeast Asian and European paediatric benchmark data.
The standardised Global-PPS was performed to assess antimicrobial use in Southeast Asia, including Sanandaj and European hospitals, in 2019.
Of the 4118, 2915, and 443 paediatric patients enrolled in Southeast Asian, European and Sanandaj hospitals, 2342 (56.9%), 833 (28.6%) and 332 (74.9%), respectively, received at least one antimicrobial in 2019. The most administered antibiotics in neonates were ampicillin in Southeast Asia (30.3%) and Sanandaj (41.5%, often in combination with cefotaxime (29.0%)), compared with amoxicillin in Europe (20.0%). In children, ceftriaxone was most prescribed in Sanandaj (62.4%) and Southeast Asia (20.5%) as opposed to amoxicillin (11.8%) in Europe. Twice as many Watch antibiotics (83.0%) were prescribed on paediatric wards in Sanandaj compared with European paediatric wards (41.1%). All antimicrobials in Sanandaj hospitals were prescribed empirically, and prolonged surgical prophylaxis was common (75.5%).
The high prevalence of antibiotic prescribing, high empirical therapies, and poor outcomes for antibiotic quality indicators strongly suggest the urgent need for an antibiotic stewardship program in Sanandaj hospitals, where improved diagnostic laboratory capacity and reconsideration of training may be good targets for intervention in their hospitals.
点 prevalence 调查 (PPS) 提供了关于医院抗菌药物管理模式的有价值的数据。为了确定质量改进指标,我们评估了伊朗西部 Sanandaj 的三个转诊中心收治的儿童和新生儿的抗菌药物处方模式,并将这些模式与东南亚和欧洲儿科基准数据进行了比较。
2019 年,对包括 Sanandaj 和欧洲医院在内的东南亚地区进行了标准化的全球 PPS,以评估抗菌药物的使用情况。
在 2019 年,东南亚、欧洲和 Sanandaj 医院分别有 4118 例、2915 例和 443 例儿科患者接受了至少一种抗菌药物治疗,其中分别有 2342 例(56.9%)、833 例(28.6%)和 332 例(74.9%)接受了抗菌药物治疗。新生儿中使用最广泛的抗生素是东南亚的氨苄西林(30.3%)和 Sanandaj(41.5%,常与头孢噻肟联合使用(29.0%)),而欧洲则是阿莫西林(20.0%)。在儿童中,头孢曲松在 Sanandaj(62.4%)和东南亚(20.5%)的使用最广泛,而欧洲则是阿莫西林(11.8%)。与欧洲儿科病房(41.1%)相比,Sanandaj 儿科病房使用的 Watch 抗生素(83.0%)是其两倍。Sanandaj 医院所有的抗生素都是经验性使用的,且延长的手术预防用药很常见(75.5%)。
抗生素处方的高患病率、高经验性治疗以及抗生素质量指标的不良结果强烈表明,Sanandaj 医院急需开展抗生素管理计划,在这些医院中,改善诊断实验室能力和重新考虑培训可能是干预的良好目标。